Literature DB >> 17237946

Early mammographic and sonographic findings after intraoperative radiotherapy (IORT) as a boost in patients with breast cancer.

K Wasser1, C Schoeber, U Kraus-Tiefenbacher, L Bauer, J Brade, J Teubner, F Wenz, W Neff.   

Abstract

The aim of this study was to evaluate mammographic and sonographic changes at the surgical site within the first 2 years after IORT as a boost followed by whole-breast radiotherapy (WBRT), compared with a control group treated with WBRT alone. All patients had breast-conserving surgery for early-stage breast cancer. Group A: n = 27, IORT (20 Gy) followed by WBRT (46 Gy). Group B (control group): n = 27, WBRT alone (56-66 Gy). Mammography: fat necrosis in 14 group A versus four group B patients (P < 0.001); parenchymal scarring classified as unorganized at the last follow-up in 16 vs seven cases, respectively (P = 0.03). Ultrasound: overall number of patients with circumscribed findings 27 vs 18 (P < 0.001); particular hematomas/seromas in 26 vs 13 patients (P < 0.001). Synopsis of mammography and ultrasound: overall postoperative changes were significantly higher classified in group A (P = 0.01), but not judged to have a significantly higher impact on interpretation. Additional diagnostic procedures, due to unclear findings at the surgical site, were performed on four patients of both groups. Within the first 2 years after IORT as a boost, therapy-induced changes at the original tumor site are significantly more pronounced compared with a control group. There is no evidence that the interpretation of findings is complicated after IORT.

Entities:  

Mesh:

Year:  2007        PMID: 17237946     DOI: 10.1007/s00330-006-0556-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

1.  [Ultrasound and mammography follow-up of findings after breast saving operation and adjuvant irradiation].

Authors:  A Mundinger; C Martini; H Madjar; J Laubenberger; H Gufler; M Langer
Journal:  Ultraschall Med       Date:  1996-02       Impact factor: 6.548

Review 2.  TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation.

Authors:  Jayant S Vaidya; Jeffrey S Tobias; Michael Baum; Frederik Wenz; Uta Kraus-Tiefenbacher; Derek D'souza; Mohammed Keshtgar; Samuele Massarut; Basil Hilaris; Christobel Saunders; David Joseph
Journal:  Semin Radiat Oncol       Date:  2005-04       Impact factor: 5.934

3.  [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand].

Authors:  W Gatzemeier; R Orecchia; G Gatti; M Intra; U Veronesi
Journal:  Strahlenther Onkol       Date:  2001-07       Impact factor: 3.621

4.  Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer.

Authors:  Mattia Intra; Giovanna Gatti; Alberto Luini; Viviana Galimberti; Paolo Veronesi; Stefano Zurrida; Antonio Frasson; Mario Ciocca; Roberto Orecchia; Umberto Veronesi
Journal:  Arch Surg       Date:  2002-06

5.  A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated.

Authors:  U Veronesi; R Orecchia; A Luini; G Gatti; M Intra; S Zurrida; G Ivaldi; G Tosi; M Ciocca; A Tosoni; F De Lucia
Journal:  Eur J Cancer       Date:  2001-11       Impact factor: 9.162

6.  Fat necrosis in the breast: sonographic features.

Authors:  M S Soo; P J Kornguth; B S Hertzberg
Journal:  Radiology       Date:  1998-01       Impact factor: 11.105

Review 7.  The mammographic spectrum of fat necrosis of the breast.

Authors:  J P Hogge; R E Robinson; C M Magnant; R A Zuurbier
Journal:  Radiographics       Date:  1995-11       Impact factor: 5.333

Review 8.  Mammography in patients with breast cancer treated by breast conservation (lumpectomy with or without radiation)

Authors:  D D Dershaw
Journal:  AJR Am J Roentgenol       Date:  1995-02       Impact factor: 3.959

9.  Ultrasonographic posttreatment follow-up of breast cancer patients.

Authors:  C Balu-Maestro; J N Bruneton; A Geoffray; C Chauvel; A Rogopoulos; O Bittman
Journal:  J Ultrasound Med       Date:  1991-01       Impact factor: 2.153

10.  Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.

Authors:  Uta Kraus-Tiefenbacher; Antonella Scheda; Volker Steil; Brigitte Hermann; Tanja Kehrer; Lelia Bauer; Frank Melchert; Frederik Wenz
Journal:  Tumori       Date:  2005 Jul-Aug
View more
  5 in total

1.  Mammographic findings after intraoperative radiotherapy of the breast.

Authors:  Ronald Rivera; Virginia Smith-Bronstein; Sylvia Villegas-Mendez; Jessica Rayhanabad; Pulin Sheth; Afshin Rashtian; Dennis R Holmes
Journal:  Radiol Res Pract       Date:  2012-02-26

Review 2.  Intraoperative radiotherapy for breast cancer: the lasting effects of a fleeting treatment.

Authors:  Harriet B Eldredge-Hindy; Anne L Rosenberg; Nicole L Simone
Journal:  Int J Breast Cancer       Date:  2014-08-10

Review 3.  Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects.

Authors:  Carsten Herskind; Lin Ma; Qi Liu; Bo Zhang; Frank Schneider; Marlon R Veldwijk; Frederik Wenz
Journal:  Radiat Oncol       Date:  2017-01-19       Impact factor: 3.481

Review 4.  Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Authors:  Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam
Journal:  Ann Surg Oncol       Date:  2009-07-17       Impact factor: 5.344

5.  Feasibility of concervative breast surgery and intraoperative radiation therapy for early breast cancer: a single-center, open, non-randomized, prospective pilot study.

Authors:  Carla Cedolini; Serena Bertozzi; Luca Seriau; Ambrogio P Londero; Serena Concina; Eugenia Moretti; Renato Padovani; Alberto Pasqualucci; Tino Ceschia; Andrea Risaliti
Journal:  Oncol Rep       Date:  2014-02-11       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.